IRIS
CHIAPPINI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.975
AS - Asia 1.191
EU - Europa 838
SA - Sud America 229
Continente sconosciuto - Info sul continente non disponibili 126
AF - Africa 29
OC - Oceania 4
Totale 8.392
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.805
SG - Singapore 551
IT - Italia 266
CN - Cina 219
BR - Brasile 186
VN - Vietnam 141
DE - Germania 125
BD - Bangladesh 124
RU - Federazione Russa 114
CA - Canada 84
IE - Irlanda 62
GB - Regno Unito 60
SE - Svezia 42
IN - India 37
HK - Hong Kong 34
MX - Messico 34
FI - Finlandia 32
LT - Lituania 24
FR - Francia 22
PL - Polonia 20
AR - Argentina 19
AT - Austria 17
NL - Olanda 17
ES - Italia 15
KR - Corea 12
ZA - Sudafrica 10
JP - Giappone 9
TR - Turchia 9
CR - Costa Rica 7
EC - Ecuador 7
IQ - Iraq 7
UZ - Uzbekistan 7
GT - Guatemala 6
HN - Honduras 6
ID - Indonesia 6
IL - Israele 6
JM - Giamaica 6
NI - Nicaragua 6
AE - Emirati Arabi Uniti 5
GP - Guadalupe 5
MA - Marocco 5
SV - El Salvador 5
CO - Colombia 4
EG - Egitto 4
HU - Ungheria 4
PK - Pakistan 4
RO - Romania 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
CW - ???statistics.table.value.countryCode.CW??? 3
EE - Estonia 3
KE - Kenya 3
PY - Paraguay 3
TN - Tunisia 3
VE - Venezuela 3
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
CZ - Repubblica Ceca 2
JO - Giordania 2
KZ - Kazakistan 2
MN - Mongolia 2
NP - Nepal 2
PE - Perù 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SC - Seychelles 2
AL - Albania 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LB - Libano 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
TW - Taiwan 1
UY - Uruguay 1
Totale 8.269
Salva come PNG Salva come JPEG
Città #
Singapore 420
Ashburn 385
San Jose 350
Dallas 184
Council Bluffs 167
Los Angeles 135
New York 118
Munich 85
Atlanta 77
Santa Clara 70
Denver 65
Dublin 62
Beijing 61
The Dalles 61
North Bergen 59
Chandler 55
Orem 52
Phoenix 47
Buffalo 46
Ho Chi Minh City 45
San Francisco 44
Chicago 36
São Paulo 36
Montreal 35
Brooklyn 29
Hong Kong 29
Rome 29
Milan 25
Hanoi 24
Memphis 22
Boston 19
Princeton 19
Toronto 19
Hefei 18
Redondo Beach 18
Tongling 18
Columbus 17
Warsaw 17
Chennai 16
Houston 15
Vilnius 15
Washington 15
Boardman 13
Frankfurt am Main 13
St Louis 13
Turku 13
Helsinki 11
London 11
Da Nang 10
Düsseldorf 10
Moscow 10
Nuremberg 9
Tokyo 9
Altamura 8
Guangzhou 8
Johannesburg 8
Kimball 8
Lappeenranta 8
Mexico City 8
Philadelphia 8
Seattle 8
Vienna 8
Amsterdam 7
Naples 7
Seoul 7
Stockholm 7
Haiphong 6
Kansas City 6
Lauterbourg 6
League City 6
Managua 6
Miami 6
Milwaukee 6
Mumbai 6
Raleigh 6
Silvi 6
Tashkent 6
Turin 6
Ankara 5
Augusta 5
Charlotte 5
Cleveland 5
Genoa 5
Guatemala City 5
Minneapolis 5
Baghdad 4
Bari 4
Bogotá 4
Brescia 4
Campinas 4
Charleston 4
Columbia 4
Gwangju 4
Hải Dương 4
Kingston 4
Kyle 4
Las Vegas 4
Louisville 4
Manchester 4
New Delhi 4
Totale 3.448
Salva come PNG Salva come JPEG
Nome #
The benzydamine experience: a systematic review of benzydamine abuse 1.141
Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review 875
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants 626
Over-the-counter Psychosis: A Systematic Review of the Misuse of Antihistamines, Cough Medicines, and Decongestants and the Risk of Developing Psychosis 534
Misuse of Anticholinergic Medications: A Systematic Review 509
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases 260
Substance-Specific Treatment Responses and Resistance Patterns in Induced Psychoses: A Scoping Review of Antipsychotic Efficacy 256
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective 215
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset 122
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation 117
3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report 116
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 116
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 114
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice 113
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review 110
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 110
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 110
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults 109
Climate change, biodiversity loss and mental health: a global perspective 108
Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature 106
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 106
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances 105
Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History 105
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 103
Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain 102
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 101
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review 100
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 99
Brexpiprazole as a new approach of treatment in somatization disorder 99
New psychoactive substances and suicidality: A systematic review of the current literature 96
To bridge or not to bridge: Moral Judgement in Cocaine Use Disorders, a case-control study on human morality 93
Alcohol Use Disorders and Suicidal Behaviour: A Narrative Review 92
Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction 92
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial 89
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study 88
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 88
Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and Outcomes 80
Opioid painkiller dependence in a sample of elderly medical inpatients 79
Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes 77
Evaluating Craving in Alcohol Use Disorder: Psychometric Characteristics of the Craving Typology Questionnaire-15 (CTQ-15) 73
Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study 70
Psychopathologic aspects of obesity: Psychodiagnostic evaluations of bariatric surgery applicants 68
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia 66
Emerging strategies and clinical recommendations for the management of novel depression subtypes 65
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward 62
Novel psychoactive substances and psychosis: A comprehensive systematic review of epidemiology, clinical features, neurobiology, and treatment 55
Alcohol vs. Cocaine: Impulsivity and Alexithymia in Substance Use Disorder 44
Anomalous self-experience in schizophrenia spectrum disorders: Phenomenological and psychopathological correlates 43
Eco-Anxiety and Mental Health: Correlates of Climate Change Distress 40
Novel psychoactive substances (NPS) as a risk factor for psychosis: A systematic review of the literature 38
Adverse Drug Reactions Associated with Concomitant Use of Calcium Channel Blockers and Cocaine: An Analysis of FDA Adverse Events Reporting System Data 38
Exploring Dual Diagnoses: Psychopathological Characteristics in the Co-Occurrence of Schizophrenia and Addiction – A Scoping Review 37
Cannabis use and psychotic-like experiences: A systematic review of biological vulnerability, potency effects, and clinical trajectories 29
Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications: An Examination of the Food and Drug Administration (FDA) Pharmacovigilance Database 26
Navigating the challenges of substance use and psychopathology in depression, bipolar disorder, and schizophrenia 23
Efficacy and Tolerability of Vortioxetine Versus Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Post-hoc Analysis of the VESPA Study 22
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor 19
Exploring emerging psychopathological characteristics and challenges of novel depression subtypes: insights from the literature 13
Totale 8.392
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.591
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.591
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202241 0 0 0 0 0 0 0 9 2 11 1 18
2022/2023199 9 25 12 10 19 37 11 17 45 4 2 8
2023/2024250 11 18 34 12 29 52 25 10 11 14 5 29
2024/2025724 60 88 51 16 27 16 32 23 69 91 125 126
2025/20262.665 174 101 174 286 236 112 275 190 284 238 330 265
2026/20274.502 1.013 1.420 1.152 752 165 0 0 0 0 0 0 0
Totale 8.392